Brainstorm Cell Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Brainstorm Cell Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Brainstorm Cell Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Brainstorm Cell Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $18 | 71 | 0.27 |
| 2023-09-30 | $7 | 39 | 0.21 |
| 2023-06-30 | $21 | 10 | 2.10 |
| 2023-03-31 | $10k | 3.0k | 3.35 |
| 2022-06-30 | $516k | 187k | 2.76 |
| 2022-03-31 | $827k | 246k | 3.36 |
| 2021-12-31 | $773k | 193k | 4.00 |
| 2021-03-31 | $3.1M | 805k | 3.83 |
| 2020-12-31 | $1.8M | 392k | 4.52 |
| 2020-09-30 | $172k | 11k | 16.15 |
| 2020-06-30 | $101k | 9.0k | 11.26 |
| 2020-03-31 | $339k | 73k | 4.65 |
| 2019-12-31 | $9.0k | 2.0k | 4.47 |
| 2018-09-30 | $395k | 104k | 3.82 |
| 2018-06-30 | $507k | 130k | 3.90 |